Decrease in mortality from benign prostatic hyperplasia

A major unheralded health triumph

Peter Boyle, Patrick Maisonneuve, Adolphe Steg

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Purpose: A systematic examination of all available mortality data from benign prostatic hyperplasia (BPH) between 1950 and 1990 was done to estimate the changing international mortality pattern of this condition. Materials and Methods: Mortality data in which BPH was the underlying cause of death were abstracted from the World Health Organization mortality data base. These data were available from a variety of international countries (in many since 1950). Results: Mortality rates have decreased with considerable magnitude in developed western countries between the early 1950s and late 1980s. This fact could reasonably be attributed to the improved management of the most severe complications of BPH and to improvements in surgery and anesthesia, which have made surgical interventions of the prostate possible in a greater proportion of men, and safer in the immediate and subsequent postoperative period. Conclusions: The decreases noted in western countries, such as the United Kingdom (where 8,700 fewer men die each year presently than would be expected if the BPH mortality rates from the early 1950s still applied), United States (13,681 fewer deaths) and France (2,884 fewer deaths), indicate a considerable but unheralded achievement for modern medicine. Unfortunately, these decreases have not been observed to the same extent in central and eastern Europe and South America, where the residual high mortality rates could be lowered by education, and the widespread availability of modern surgical and anesthetic equipment.

Original languageEnglish
Pages (from-to)176-180
Number of pages5
JournalJournal of Urology
Volume155
Issue number1
Publication statusPublished - Jan 1996

Fingerprint

Prostatic Hyperplasia
Mortality
Health
Surgical Equipment
Eastern Europe
Modern 1601-history
South America
Developed Countries
Postoperative Period
France
Anesthetics
Prostate
Cause of Death
Anesthesia
Databases
Education

Keywords

  • Mortality
  • Prostatic diseases
  • Prostatic hypertrophy
  • Survival

ASJC Scopus subject areas

  • Urology

Cite this

Decrease in mortality from benign prostatic hyperplasia : A major unheralded health triumph. / Boyle, Peter; Maisonneuve, Patrick; Steg, Adolphe.

In: Journal of Urology, Vol. 155, No. 1, 01.1996, p. 176-180.

Research output: Contribution to journalArticle

@article{cfa8a7fcaf9b466f99f010166da2e550,
title = "Decrease in mortality from benign prostatic hyperplasia: A major unheralded health triumph",
abstract = "Purpose: A systematic examination of all available mortality data from benign prostatic hyperplasia (BPH) between 1950 and 1990 was done to estimate the changing international mortality pattern of this condition. Materials and Methods: Mortality data in which BPH was the underlying cause of death were abstracted from the World Health Organization mortality data base. These data were available from a variety of international countries (in many since 1950). Results: Mortality rates have decreased with considerable magnitude in developed western countries between the early 1950s and late 1980s. This fact could reasonably be attributed to the improved management of the most severe complications of BPH and to improvements in surgery and anesthesia, which have made surgical interventions of the prostate possible in a greater proportion of men, and safer in the immediate and subsequent postoperative period. Conclusions: The decreases noted in western countries, such as the United Kingdom (where 8,700 fewer men die each year presently than would be expected if the BPH mortality rates from the early 1950s still applied), United States (13,681 fewer deaths) and France (2,884 fewer deaths), indicate a considerable but unheralded achievement for modern medicine. Unfortunately, these decreases have not been observed to the same extent in central and eastern Europe and South America, where the residual high mortality rates could be lowered by education, and the widespread availability of modern surgical and anesthetic equipment.",
keywords = "Mortality, Prostatic diseases, Prostatic hypertrophy, Survival",
author = "Peter Boyle and Patrick Maisonneuve and Adolphe Steg",
year = "1996",
month = "1",
language = "English",
volume = "155",
pages = "176--180",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Decrease in mortality from benign prostatic hyperplasia

T2 - A major unheralded health triumph

AU - Boyle, Peter

AU - Maisonneuve, Patrick

AU - Steg, Adolphe

PY - 1996/1

Y1 - 1996/1

N2 - Purpose: A systematic examination of all available mortality data from benign prostatic hyperplasia (BPH) between 1950 and 1990 was done to estimate the changing international mortality pattern of this condition. Materials and Methods: Mortality data in which BPH was the underlying cause of death were abstracted from the World Health Organization mortality data base. These data were available from a variety of international countries (in many since 1950). Results: Mortality rates have decreased with considerable magnitude in developed western countries between the early 1950s and late 1980s. This fact could reasonably be attributed to the improved management of the most severe complications of BPH and to improvements in surgery and anesthesia, which have made surgical interventions of the prostate possible in a greater proportion of men, and safer in the immediate and subsequent postoperative period. Conclusions: The decreases noted in western countries, such as the United Kingdom (where 8,700 fewer men die each year presently than would be expected if the BPH mortality rates from the early 1950s still applied), United States (13,681 fewer deaths) and France (2,884 fewer deaths), indicate a considerable but unheralded achievement for modern medicine. Unfortunately, these decreases have not been observed to the same extent in central and eastern Europe and South America, where the residual high mortality rates could be lowered by education, and the widespread availability of modern surgical and anesthetic equipment.

AB - Purpose: A systematic examination of all available mortality data from benign prostatic hyperplasia (BPH) between 1950 and 1990 was done to estimate the changing international mortality pattern of this condition. Materials and Methods: Mortality data in which BPH was the underlying cause of death were abstracted from the World Health Organization mortality data base. These data were available from a variety of international countries (in many since 1950). Results: Mortality rates have decreased with considerable magnitude in developed western countries between the early 1950s and late 1980s. This fact could reasonably be attributed to the improved management of the most severe complications of BPH and to improvements in surgery and anesthesia, which have made surgical interventions of the prostate possible in a greater proportion of men, and safer in the immediate and subsequent postoperative period. Conclusions: The decreases noted in western countries, such as the United Kingdom (where 8,700 fewer men die each year presently than would be expected if the BPH mortality rates from the early 1950s still applied), United States (13,681 fewer deaths) and France (2,884 fewer deaths), indicate a considerable but unheralded achievement for modern medicine. Unfortunately, these decreases have not been observed to the same extent in central and eastern Europe and South America, where the residual high mortality rates could be lowered by education, and the widespread availability of modern surgical and anesthetic equipment.

KW - Mortality

KW - Prostatic diseases

KW - Prostatic hypertrophy

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0029655439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029655439&partnerID=8YFLogxK

M3 - Article

VL - 155

SP - 176

EP - 180

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -